Overbought Stocks
HIMS appears in our Overbought Stocks screen, meaning it has experienced strong recent gains and may be trading at extended levels that could lead to short-term consolidation or pullback.
HIMS & HERS HEALTH INC (HIMS) Stock Price & Overview
NYSE:HIMS • US4330001060
Current stock price
29.01 USD
-0.75 (-2.52%)
At close:
29.051 USD
+0.04 (+0.14%)
After Hours:
The current stock price of HIMS is 29.01 USD. Today HIMS is down by -2.52%. In the past month the price increased by 32.5%. In the past year, price increased by 5.95%.
HIMS Key Statistics
52-Week Range13.74 - 70.43
Current HIMS stock price positioned within its 52-week range.
1-Month Range18.62 - 31.855
Current HIMS stock price positioned within its 1-month range.
- Market Cap
- 6.613B
- P/E
- 56.88
- Fwd P/E
- 49.90
- EPS (TTM)
- 0.51
- Dividend Yield
- N/A
HIMS Stock Performance
Today
-2.52%
1 Week
+39.33%
1 Month
+32.50%
3 Months
+0.47%
Longer-term
6 Months -38.99%
1 Year +5.95%
2 Years +137.51%
3 Years +156.77%
5 Years +140.39%
10 Years N/A
HIMS Stock Chart
HIMS Stock Screens
HIMS currently appears in the following ChartMill screener lists.
HIMS Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to HIMS. When comparing the yearly performance of all stocks, HIMS turns out to be only a medium performer in the overall market: it outperformed 44.95% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
HIMS Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to HIMS. HIMS has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
HIMS Earnings
On February 23, 2026 HIMS reported an EPS of 0.08 and a revenue of 617.82M. The company beat EPS expectations (71.14% surprise) and missed revenue expectations (-2.18% surprise).
Next Earnings DateMay 11, 2026
Last Earnings DateFeb 23, 2026
PeriodQ4 / 2025
EPS Reported$0.08
Revenue Reported617.818M
EPS Surprise 71.14%
Revenue Surprise -2.18%
HIMS Forecast & Estimates
22 analysts have analysed HIMS and the average price target is 25.34 USD. This implies a price decrease of -12.66% is expected in the next year compared to the current price of 29.01.
For the next year, analysts expect an EPS growth of 14% and a revenue growth 17.4% for HIMS
Analysts
Analysts70
Price Target25.34 (-12.65%)
EPS Next Y14%
Revenue Next Year17.4%
HIMS Groups
Sector & Classification
HIMS Financial Highlights
Over the last trailing twelve months HIMS reported a non-GAAP Earnings per Share(EPS) of 0.51. The EPS decreased by -5.56% compared to the year before.
Income Statements
Revenue(TTM)2.35B
Net Income(TTM)128.37M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.47% | ||
| ROA | 5.96% | ||
| ROE | 23.73% | ||
| Debt/Equity | 1.8 |
Chartmill High Growth Momentum
EPS Q2Q%-27.27%
Sales Q2Q%28.41%
EPS 1Y (TTM)-5.56%
Revenue 1Y (TTM)59%
HIMS Ownership
Ownership
Inst Owners85.5%
Shares227.94M
Float207.12M
Ins Owners5.53%
Short Float %34.53%
Short Ratio1.84
HIMS Competitors/Peers
The largest stocks on the US markets in the "Health Care Services" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 10.56 | 99.145B | ||
| CI | THE CIGNA GROUP | 8.79 | 72.952B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 98.6 | 29.499B | ||
| DGX | QUEST DIAGNOSTICS INC | 17.65 | 22.694B | ||
| LH | LABCORP HOLDINGS INC | 14.8 | 22.472B | ||
| GH | GUARDANT HEALTH INC | N/A | 11.853B | ||
| DVA | DAVITA INC | 10.79 | 10.013B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 29.69 | 8.905B | ||
| CHE | CHEMED CORP | 15.47 | 5.461B | ||
| RDNT | RADNET INC | 88.39 | 4.463B | ||
| OPCH | OPTION CARE HEALTH INC | 14.93 | 4.404B | ||
| BLLN | BILLIONTOONE INC CL A | 178.27 | 4.091B |
Related stock screener links
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About HIMS
Company Profile
Hims & Hers Health, Inc. operates a telehealth consultation platform. The company is headquartered in San Francisco, California and currently employs 2,442 full-time employees. The company went IPO on 2019-09-09. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of chronic conditions, including those related to sexual health, hair loss, dermatology, mental health, and weight loss. The company connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies on a subscription basis. The company also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. Through its mobile applications, consumers can access a range of educational programs, wellness content, and other services.
Company Info
IPO: 2019-09-09
HIMS & HERS HEALTH INC
2269 Chestnut St, #523
San Francisco CALIFORNIA 94123 US
CEO: Andrew Dudum
Employees: 2442
Phone: 18003166660
HIMS & HERS HEALTH INC / HIMS FAQ
What does HIMS & HERS HEALTH INC do?
Hims & Hers Health, Inc. operates a telehealth consultation platform. The company is headquartered in San Francisco, California and currently employs 2,442 full-time employees. The company went IPO on 2019-09-09. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of chronic conditions, including those related to sexual health, hair loss, dermatology, mental health, and weight loss. The company connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies on a subscription basis. The company also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. Through its mobile applications, consumers can access a range of educational programs, wellness content, and other services.
What is the stock price of HIMS & HERS HEALTH INC today?
The current stock price of HIMS is 29.01 USD. The price decreased by -2.52% in the last trading session.
Does HIMS & HERS HEALTH INC pay dividends?
HIMS does not pay a dividend.
What is the ChartMill technical and fundamental rating of HIMS stock?
HIMS has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Is HIMS & HERS HEALTH INC (HIMS) expected to grow?
The Revenue of HIMS & HERS HEALTH INC (HIMS) is expected to grow by 17.4% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the market capitalization of HIMS stock?
HIMS & HERS HEALTH INC (HIMS) has a market capitalization of 6.61B USD. This makes HIMS a Mid Cap stock.
What is the outstanding short interest for HIMS & HERS HEALTH INC?
The outstanding short interest for HIMS & HERS HEALTH INC (HIMS) is 34.53% of its float.